{"url_path":"/sec/md/8-k/2026-07-15/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/893949/0001193125-26-304033-index.html","accession_number":"0001193125-26-304033","cik":"0000893949","ticker":"MD","issuer_name":"Pediatrix Medical Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/893949/0001193125-26-304033-index.html","primary_entity_key":"0000893949","primary_entity_name":"Pediatrix Medical Group, Inc."},"word_count":65,"has_tables":true,"body_markdown":"## Item 2.02 Results of Operations and Financial Condition.\n\nOn July 15, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release providing an update for the Company’s recently completed second quarter (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02."}